Alpha-GPC: Evidence, Side Effects and the Stroke-Risk Signal in Observational Research
What studies found for alpha-GPC in dementia, healthy adults and exercise, and how to read the large Korean study that linked prescribed alpha-GPC to more strokes.
Content last updated . This page has not been medically reviewed.
Evidence labels: promising but limited, mixed, insufficient evidence, evidence of harm (not established here). See What are nootropics? and the overview Citicoline and Alpha-GPC.
The stroke signal, step by step
| Item | What the source reports |
|---|---|
| Who | About 12 million people in South Korea's national health insurance data, aged 50 and older, with no earlier stroke or Alzheimer's disease. [1] |
| Exposure | Having been prescribed alpha-GPC in 2006 to 2008 (108,877 users), followed to 2018. [1] |
| Result | Users had a higher risk of total stroke (adjusted hazard ratio 1.46; after matching 1.43), and higher risk with increasing intake. [1] |
| Group differences | Users were older on average (68.3 versus 61.6 years before matching). [1] |
| Authors' conclusion | Alpha-GPC use was associated with higher 10-year stroke risk; future studies are needed on possible mechanisms. [1] |
| Correction | A 2026 erratum corrected the codes used to define ischemic and hemorrhagic stroke in the Methods and an author-contribution name. It does not say the results changed. [2] |
How to read it. This is an observational study. People prescribed alpha-GPC may have had other health differences that were not fully measured, such as early memory decline, and the study counted prescriptions, not supplement purchases. The authors adjusted for traditional stroke risk factors and still saw the pattern. [1] The abstract notes that choline has previously been linked to cardiovascular risk through a gut-bacteria by-product (TMAO), but whether that explains the finding is not shown. [1] This study alone cannot tell whether using or avoiding alpha-GPC changes anyone's stroke risk. People with a history of stroke, heart disease or clot-preventing medicines should talk with a clinician or pharmacist before any such product. Never stop a prescribed medicine on your own.
Evidence for cognition
| Question | What the source found | Strength |
|---|---|---|
| Adult-onset cognitive impairment | Meta-analysis (2023) of seven randomized trials and one cohort study: improved cognition, function and behavior when added to donepezil, and better cognition than placebo or other medicines in one comparison. Authors' conclusion concerned conditions associated with cerebrovascular injury. [3] | Limited |
| Alpha-GPC versus citicoline in dementia | Meta-analysis (2025), three trials, 358 people: a clinical rating scale favored alpha-GPC; no difference on memory or word-fluency tests. [4] | Limited |
| Mild to moderate impairment, as add-on to usual treatment | Meta-analysis of three trials (2026, English abstract): higher Montreal Cognitive Assessment scores than controls, high heterogeneity, adverse events similar to the control group. [5] | Limited |
| Healthy young men, single occasion | 20 resistance-trained men (average age 31) in a crossover trial: larger Stroop total-score changes after two single amounts of alpha-GPC than after placebo, and faster Stroop completion at the higher amount; no differences on Flanker or N-Back tests. [6] | Insufficient (small, short) |
| Healthy older adults, daily memory | Proper evidence not found. We searched PubMed for alpha-GPC trials and reviews and found none in healthy older adults. | Insufficient |
Evidence for strength and exercise
Searches for "alpha GPC for strength" found small trials in young men. In 13 college-aged men, six days of 600 mg a day (study amount) was followed by a bigger change in mid-thigh pull force than placebo, while the upper-body test was not significant. [7] In 48 healthy college-aged men given 250 mg or 500 mg of alpha-GPC, 200 mg of caffeine or placebo daily for 7 days, there were no group differences in isometric strength or a psychomotor vigilance test; jump measures differed (largest change in the lower alpha-GPC group), and thyroid-stimulating hormone was lower in the higher-amount group. [8] These are tiny short studies of one population; results do not transfer to women, older adults or athletes in competition. Label: insufficient evidence.Side effects and safety
- Stroke association as above. [1]
- Heart rate and blood pressure. In the single-occasion trial, heart rate and blood pressure changed in all groups, including placebo, with values within normal ranges. [6]
- Hormone marker. Lower thyroid-stimulating hormone was seen in one study group; what it means for health is not described in that abstract. [8]
- Common side effects, medicines, pregnancy, children, kidney, liver, surgery: not described in the sources we read, so none is stated. In the dementia trials it was often used alongside donepezil, so no conclusions about taking it with other medicines can be drawn. [3] Ask a pharmacist: medication interactions; tell your surgical team (supplements before surgery).
- Products. Alpha-GPC has appeared in disease-claim warnings from the FDA; check reading supplement labels and quality testing. [9]
When to get help
Sudden face drooping, weakness, speech trouble or severe headache is an emergency: call 911 in the US. Ongoing memory change needs evaluation: mild cognitive impairment and dementia.Frequently asked questions
Does alpha-GPC cause stroke?
Not proven. A large Korean study found an association between prescribed alpha-GPC and stroke over 10 years, but observational studies cannot prove cause. [1]
Does alpha-GPC improve memory?
In people with cognitive impairment, small trials suggest some benefit on rating scales, with limits. [3][5] Healthy-adult memory evidence: Proper evidence not found.
Does alpha-GPC build strength?
Two small studies in young men gave mixed results: one showed more force after six days, the other showed no strength difference. [7][8]
Is alpha-GPC better than citicoline?
A 2025 meta-analysis of three dementia trials favored alpha-GPC on one scale, not on memory tests. [4]
Is it safe to take with other medicines?
We did not find a source we could read that answers this. Ask a pharmacist. [3]
References
- Lee G et al. JAMA Netw Open 2021. Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. Read 2026-10-23.
- JAMA Netw Open 2026. Errors in Methods and Article Information (erratum for the 2021 alpha-GPC stroke study). Read 2026-10-23.
- Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis. J Alzheimers Dis 2023. PubMed record. Read 2026-10-23.
- Sagaro GG, Amenta F. Front Neurol 2025. Comparison of the effects of choline alphoscerate and citicoline in patients with dementia disorders: a systematic review and meta-analysis. Read 2026-10-23.
- Choline alfoscerate in pre-dementia cognitive impairment: a systematic review and meta-analysis of randomized trials. Zh Nevrol Psikhiatr Im S S Korsakova 2026. PubMed record (English abstract). Read 2026-10-23.
- Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men. Nutrients 2024. PubMed record. Read 2026-10-23.
- The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. J Int Soc Sports Nutr 2015. PubMed record. Read 2026-10-23.
- Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. J Int Soc Sports Nutr 2017. PubMed record. Read 2026-10-23.
- US Food and Drug Administration (with the Federal Trade Commission), Warning letter to an online seller of nootropic products, 565425 (February 5, 2019). Read 2026-10-23.